(Reuters) – Inovio Pharmaceuticals Inc said on Thursday it received authorization from Brazil’s regulatory agency to conduct mid-to-late stage trial of its COVID-19 vaccine.
(Reporting by Mrinalika Roy in Bengaluru)
Inovio to start COVID-19 vaccine trial after getting Brazil regulator approval
Peoria, IL, USA
60 °F Sunny
